Cita APA

Moya Ayre, E. F., & Bermúdez Maldonado, I. (2016). Adalimumab, therapeutic alternative in the Vogt Koyanagi Harada syndrome refractory to infliximab: Case report.

Citación estilo Chicago

Moya Ayre, Eugenio Franklin, y Iván Bermúdez Maldonado. Adalimumab, Therapeutic Alternative in the Vogt Koyanagi Harada Syndrome Refractory to Infliximab: Case Report. 2016.

Cita MLA

Moya Ayre, Eugenio Franklin, y Iván Bermúdez Maldonado. Adalimumab, Therapeutic Alternative in the Vogt Koyanagi Harada Syndrome Refractory to Infliximab: Case Report. 2016.